CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS
Clinical trials for CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New liver drug safety trial aims to help hepatitis b patients
Disease control Recruiting nowThis study tests whether high doses of hydronidone capsules are safe for people with liver scarring (fibrosis) or cirrhosis caused by chronic hepatitis B. About 300 adults will take the drug three times daily for 28 days and be monitored for side effects. The goal is to see if th…
Matched conditions: CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS
Phase: PHASE3 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated May 17, 2026 12:28 UTC
-
New liver fibrosis drug safety trial begins
Disease control Recruiting nowThis study tests the safety of a drug called hydronidone in 200 adults with liver scarring (fibrosis) caused by chronic hepatitis B or fatty liver disease. Participants take three capsules three times a day for 28 days. The main goal is to track any side effects that occur during…
Matched conditions: CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS
Phase: PHASE2 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated May 17, 2026 12:24 UTC